DKK416.40
2.51% today
Copenhagen, Nov 26, 05:00 pm CET
ISIN
DK0060336014
Symbol
NSIS B
Industry

Novonesis Target price 2024 - Analyst rating & recommendation

Novonesis Classifications & Recommendation:

Buy
63%
Hold
26%
Sell
11%

Novonesis Price Target

Target Price DKK498.85
Price DKK427.10
Potential
Number of Estimates 17
17 Analysts have issued a price target Novonesis 2025 . The average Novonesis target price is DKK498.85. This is higher than the current stock price. The highest price target is
DKK585.99 37.20%
register free of charge
, the lowest is
DKK364.00 14.77%
register free of charge
.
A rating was issued by 19 analysts: 12 Analysts recommend Novonesis to buy, 5 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Novonesis stock has an average upside potential 2025 of . Most analysts recommend the Novonesis stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion DKK 17.90 29.47
64.63%
EBITDA Margin 32.72% 34.49%
5.42%
Net Margin 16.92% 5.30%
68.67%

16 Analysts have issued a sales forecast Novonesis 2024 . The average Novonesis sales estimate is

DKK29.5b
Unlock
. This is
64.63% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
DKK30.1b 68.27%
Unlock
, the lowest is
DKK28.4b 58.72%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 DKK17.9b
2024
DKK29.5b 64.63%
Unlock
2025
DKK31.6b 7.28%
Unlock
2026
DKK33.8b 6.97%
Unlock
2027
DKK35.9b 6.19%
Unlock
2028
DKK38.6b 7.63%
Unlock

16 Analysts have issued an Novonesis EBITDA forecast 2024. The average Novonesis EBITDA estimate is

DKK10.2b
Unlock
. This is
74.19% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
DKK10.8b 85.59%
Unlock
, the lowest is
DKK8.1b 38.32%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 DKK5.9b
2024
DKK10.2b 73.53%
Unlock
2025
DKK11.8b 15.82%
Unlock
2026
DKK12.8b 9.08%
Unlock
2027
DKK13.7b 7.08%
Unlock
2028
DKK15.0b 8.83%
Unlock

EBITDA Margin

2023 32.72%
2024
34.49% 5.42%
Unlock
2025
37.23% 7.94%
Unlock
2026
37.97% 1.99%
Unlock
2027
38.28% 0.82%
Unlock
2028
38.71% 1.12%
Unlock

11 Novonesis Analysts have issued a net profit forecast 2024. The average Novonesis net profit estimate is

DKK1.6b
Unlock
. This is
48.40% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
DKK3.4b 12.79%
Unlock
, the lowest is
DKK679m 77.56%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 DKK3.0b
2024
DKK1.6b 48.45%
Unlock
2025
DKK3.1b 100.35%
Unlock
2026
DKK3.7b 17.65%
Unlock
2027
DKK3.9b 5.40%
Unlock
2028
DKK4.3b 11.47%
Unlock

Net Margin

2023 16.92%
2024
5.30% 68.67%
Unlock
2025
9.89% 86.60%
Unlock
2026
10.88% 10.01%
Unlock
2027
10.80% 0.74%
Unlock
2028
11.19% 3.61%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share DKK 10.92 5.63
48.44%
P/E 75.87
EV/Sales 6.97

11 Analysts have issued a Novonesis forecast for earnings per share. The average Novonesis <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

DKK5.63
Unlock
. This is
48.40% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
DKK12.31 12.83%
Unlock
, the lowest is
DKK2.45 77.54%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 DKK10.92
2024
DKK5.63 48.44%
Unlock
2025
DKK11.28 100.36%
Unlock
2026
DKK13.27 17.64%
Unlock
2027
DKK13.98 5.35%
Unlock
2028
DKK15.59 11.52%
Unlock

P/E ratio

Current 39.13 24.86%
2024
75.87 93.89%
Unlock
2025
37.87 50.09%
Unlock
2026
32.19 15.00%
Unlock
2027
30.54 5.13%
Unlock
2028
27.40 10.28%
Unlock

Based on analysts' sales estimates for 2024, the Novonesis stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 11.48 91.33%
2024
6.97 39.27%
Unlock
2025
6.50 6.79%
Unlock
2026
6.08 6.52%
Unlock
2027
5.72 5.83%
Unlock
2028
5.32 7.09%
Unlock

P/S ratio

Current 11.09 96.33%
2024
6.73 39.26%
Unlock
2025
6.28 6.79%
Unlock
2026
5.87 6.52%
Unlock
2027
5.53 5.83%
Unlock
2028
5.13 7.09%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today